Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug;50(2):278-280.
doi: 10.1007/s11239-020-02129-0.

Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy

F Burcu Belen-Apak  1 , F Sarıalioğlu  2
Affiliations
Comment

Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy

F Burcu Belen-Apak et al. J Thromb Thrombolysis. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors FBBA and FS declare no conflict of interest.

Figures

Fig. 1
Fig. 1
The possible pathogenesis of COVID-19. TPA tissue plasminogen activator, aPTT activated partial thromboplastin time, PT prothrombin time, HLH hemophagocytic lymphohistiocytosis, MAS macrophage activating syndrome, LMWH low molecular weight heparin
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Thachil J. The versatile heparin in COVID-19. J Thromb Haemost. 2020 doi: 10.1111/jth.14821. - DOI - PMC - PubMed
    1. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi: 10.1111/jth.14768. - DOI - PMC - PubMed
    1. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–847. doi: 10.1111/jth.14768. - DOI - PMC - PubMed
    1. McGonagle D, O’Donnell JS, Sharif K, Emery P, Bridgewood C. Why the immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia are distinct from macrophage activation syndrome with disseminated Intravascular coagulation. Autoimmun Rev. 2020 doi: 10.1016/j.autrev.2020.102537. - DOI - PMC - PubMed
    1. Fox SE, Akmatbekov A, Harbert JL, Li G, Brown Q, Vander Heide RS. Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans. MedRxiv. 2020 doi: 10.1101/2020.04.06.20050575. - DOI - PMC - PubMed